Cloning of Variable Domains from Mouse Hybridoma by PCR View Full Text


Ontology type: schema:Chapter     


Chapter Info

DATE

2010

AUTHORS

Nina Strebe , Frank Breitling , Dieter Moosmayer , Bodo Brocks , Stefan Dübel

ABSTRACT

Some hybridoma cell lines are very low producers, difficult to cultivate, or antibody production is lost upon prolonged culture. In these cases, a recombinant "hybridoma immortalization" can rescue a valuable antibody for further unlimited propagation in E. coli or other recombinant production systems. Further, monoclonal antibodies with promising specificity, but low affinity, can be improved by phage display, or mouse antibodies can be humanised for therapy. This chapter describes sets of thoroughly validated oligonucleotide primers for a PCR procedure to isolate and clone the DNA of antibody Fv fragments (antigen binding region) from mouse and rat hybridoma cell lines. The protocol includes a colony staining assay to identify E. coli clones producing scFv antibody fragments. More... »

PAGES

3-14

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/978-3-642-01144-3_1

DOI

http://dx.doi.org/10.1007/978-3-642-01144-3_1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1047878459


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1107", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Immunology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Sanofi (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420214.1", 
          "name": [
            "Institut f\u00fcr Biochemie und Biotechnologie, Technische Universit\u00e4t Braunschweig, Spielmannstr. 7, 38106, Braunschweig, Germany", 
            "Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Bldg. H790, 65926, Frankfurt am Main, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strebe", 
        "givenName": "Nina", 
        "id": "sg:person.0622544220.05", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622544220.05"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Karlsruhe Institute of Technology", 
          "id": "https://www.grid.ac/institutes/grid.7892.4", 
          "name": [
            "Karlsruhe Institute of Technology, Helmholtzplatz 1, 76344 Eggenstein-Leopoldshafen, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Breitling", 
        "givenName": "Frank", 
        "id": "sg:person.01210437462.56", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210437462.56"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Bayer (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.420044.6", 
          "name": [
            "Bayer Schering Pharma AG, M\u00fcllerstr. 178, 13342, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Moosmayer", 
        "givenName": "Dieter", 
        "id": "sg:person.01202331433.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202331433.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MorphoSys (Germany)", 
          "id": "https://www.grid.ac/institutes/grid.476513.2", 
          "name": [
            "Bodo Brocks, MorphoSys AG, Lena-Christ-Str. 48, 82152, Martinsried, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Brocks", 
        "givenName": "Bodo", 
        "id": "sg:person.0646353163.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646353163.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Braunschweig University of Technology", 
          "id": "https://www.grid.ac/institutes/grid.6738.a", 
          "name": [
            "Institut f\u00fcr Biochemie und Biotechnologie, Technische Universit\u00e4t Braunschweig, Spielmannstr. 7, 38106, Braunschweig, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "D\u00fcbel", 
        "givenName": "Stefan", 
        "id": "sg:person.01102431427.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102431427.44"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1002/(sici)1099-1352(199903/04)12:2<103::aid-jmr447>3.0.co;2-b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009704394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0014-5793(97)00983-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009855139"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02789479", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032005049", 
          "https://doi.org/10.1007/bf02789479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(94)90334-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033584582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0022-1759(94)90334-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033584582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jim.2008.10.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045893716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1128/mcb.5.12.3610", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047737361"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/hyb.1997.16.227", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059275707"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf03401851", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074947219", 
          "https://doi.org/10.1007/bf03401851"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082410085", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010", 
    "datePublishedReg": "2010-01-01", 
    "description": "Some hybridoma cell lines are very low producers, difficult to cultivate, or antibody production is lost upon prolonged culture. In these cases, a recombinant \"hybridoma immortalization\" can rescue a valuable antibody for further unlimited propagation in E. coli or other recombinant production systems. Further, monoclonal antibodies with promising specificity, but low affinity, can be improved by phage display, or mouse antibodies can be humanised for therapy. This chapter describes sets of thoroughly validated oligonucleotide primers for a PCR procedure to isolate and clone the DNA of antibody Fv fragments (antigen binding region) from mouse and rat hybridoma cell lines. The protocol includes a colony staining assay to identify E. coli clones producing scFv antibody fragments.", 
    "editor": [
      {
        "familyName": "Kontermann", 
        "givenName": "Roland", 
        "type": "Person"
      }, 
      {
        "familyName": "D\u00fcbel", 
        "givenName": "Stefan", 
        "type": "Person"
      }
    ], 
    "genre": "chapter", 
    "id": "sg:pub.10.1007/978-3-642-01144-3_1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": {
      "isbn": [
        "978-3-642-01143-6", 
        "978-3-642-01144-3"
      ], 
      "name": "Antibody Engineering", 
      "type": "Book"
    }, 
    "name": "Cloning of Variable Domains from Mouse Hybridoma by PCR", 
    "pagination": "3-14", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1047878459"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/978-3-642-01144-3_1"
        ]
      }, 
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e414e79123675495691b862ec4d2fde62e6e66721edccc713de30c4c575b5ee6"
        ]
      }
    ], 
    "publisher": {
      "location": "Berlin, Heidelberg", 
      "name": "Springer Berlin Heidelberg", 
      "type": "Organisation"
    }, 
    "sameAs": [
      "https://doi.org/10.1007/978-3-642-01144-3_1", 
      "https://app.dimensions.ai/details/publication/pub.1047878459"
    ], 
    "sdDataset": "chapters", 
    "sdDatePublished": "2019-04-16T07:30", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000356_0000000356/records_57880_00000000.jsonl", 
    "type": "Chapter", 
    "url": "https://link.springer.com/10.1007%2F978-3-642-01144-3_1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-01144-3_1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-01144-3_1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-01144-3_1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/978-3-642-01144-3_1'


 

This table displays all metadata directly associated to this object as RDF triples.

139 TRIPLES      23 PREDICATES      36 URIs      20 LITERALS      8 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/978-3-642-01144-3_1 schema:about anzsrc-for:11
2 anzsrc-for:1107
3 schema:author N0897768aeeee4216bda060dd08e89359
4 schema:citation sg:pub.10.1007/bf02789479
5 sg:pub.10.1007/bf03401851
6 https://app.dimensions.ai/details/publication/pub.1082410085
7 https://doi.org/10.1002/(sici)1099-1352(199903/04)12:2<103::aid-jmr447>3.0.co;2-b
8 https://doi.org/10.1016/0022-1759(94)90334-4
9 https://doi.org/10.1016/j.jim.2008.10.012
10 https://doi.org/10.1016/s0014-5793(97)00983-6
11 https://doi.org/10.1089/hyb.1997.16.227
12 https://doi.org/10.1128/mcb.5.12.3610
13 schema:datePublished 2010
14 schema:datePublishedReg 2010-01-01
15 schema:description Some hybridoma cell lines are very low producers, difficult to cultivate, or antibody production is lost upon prolonged culture. In these cases, a recombinant "hybridoma immortalization" can rescue a valuable antibody for further unlimited propagation in E. coli or other recombinant production systems. Further, monoclonal antibodies with promising specificity, but low affinity, can be improved by phage display, or mouse antibodies can be humanised for therapy. This chapter describes sets of thoroughly validated oligonucleotide primers for a PCR procedure to isolate and clone the DNA of antibody Fv fragments (antigen binding region) from mouse and rat hybridoma cell lines. The protocol includes a colony staining assay to identify E. coli clones producing scFv antibody fragments.
16 schema:editor Nbd092a3c530d4513ae6c1ff3f38ee97a
17 schema:genre chapter
18 schema:inLanguage en
19 schema:isAccessibleForFree false
20 schema:isPartOf N2cd3b342510f4d73870de5b6e8eafc43
21 schema:name Cloning of Variable Domains from Mouse Hybridoma by PCR
22 schema:pagination 3-14
23 schema:productId N10f096a86ce3473a95061a98b114dae8
24 Nbd1e550305be444ea97578cd88ac86a6
25 Nc8f107b723ff419397c968cdef865471
26 schema:publisher N41718e660b24472f8ff3e8dfcd47a81c
27 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047878459
28 https://doi.org/10.1007/978-3-642-01144-3_1
29 schema:sdDatePublished 2019-04-16T07:30
30 schema:sdLicense https://scigraph.springernature.com/explorer/license/
31 schema:sdPublisher N0cf9d97582294c9b8f89b9f9acf9f86c
32 schema:url https://link.springer.com/10.1007%2F978-3-642-01144-3_1
33 sgo:license sg:explorer/license/
34 sgo:sdDataset chapters
35 rdf:type schema:Chapter
36 N0897768aeeee4216bda060dd08e89359 rdf:first sg:person.0622544220.05
37 rdf:rest Nda53ac713a004be897b4fe0c6649b049
38 N0cf9d97582294c9b8f89b9f9acf9f86c schema:name Springer Nature - SN SciGraph project
39 rdf:type schema:Organization
40 N10f096a86ce3473a95061a98b114dae8 schema:name dimensions_id
41 schema:value pub.1047878459
42 rdf:type schema:PropertyValue
43 N2cd3b342510f4d73870de5b6e8eafc43 schema:isbn 978-3-642-01143-6
44 978-3-642-01144-3
45 schema:name Antibody Engineering
46 rdf:type schema:Book
47 N37d045e029f14a40a2e3990dcb09798f schema:familyName Kontermann
48 schema:givenName Roland
49 rdf:type schema:Person
50 N41718e660b24472f8ff3e8dfcd47a81c schema:location Berlin, Heidelberg
51 schema:name Springer Berlin Heidelberg
52 rdf:type schema:Organisation
53 Na50f4e6e48654bffa45139cf8dcf58e9 rdf:first Nc333d8acb5d1423c9cd4bb8d19442247
54 rdf:rest rdf:nil
55 Na69d32e77c904d99abbf0d9ea63ef29d rdf:first sg:person.01202331433.19
56 rdf:rest Na908c27b6af64dcbb3eabecc1962c6ae
57 Na908c27b6af64dcbb3eabecc1962c6ae rdf:first sg:person.0646353163.21
58 rdf:rest Nb5b2f71de9aa4c8f89371b033ea762ae
59 Nb5b2f71de9aa4c8f89371b033ea762ae rdf:first sg:person.01102431427.44
60 rdf:rest rdf:nil
61 Nbd092a3c530d4513ae6c1ff3f38ee97a rdf:first N37d045e029f14a40a2e3990dcb09798f
62 rdf:rest Na50f4e6e48654bffa45139cf8dcf58e9
63 Nbd1e550305be444ea97578cd88ac86a6 schema:name doi
64 schema:value 10.1007/978-3-642-01144-3_1
65 rdf:type schema:PropertyValue
66 Nc333d8acb5d1423c9cd4bb8d19442247 schema:familyName Dübel
67 schema:givenName Stefan
68 rdf:type schema:Person
69 Nc8f107b723ff419397c968cdef865471 schema:name readcube_id
70 schema:value e414e79123675495691b862ec4d2fde62e6e66721edccc713de30c4c575b5ee6
71 rdf:type schema:PropertyValue
72 Nda53ac713a004be897b4fe0c6649b049 rdf:first sg:person.01210437462.56
73 rdf:rest Na69d32e77c904d99abbf0d9ea63ef29d
74 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
75 schema:name Medical and Health Sciences
76 rdf:type schema:DefinedTerm
77 anzsrc-for:1107 schema:inDefinedTermSet anzsrc-for:
78 schema:name Immunology
79 rdf:type schema:DefinedTerm
80 sg:person.01102431427.44 schema:affiliation https://www.grid.ac/institutes/grid.6738.a
81 schema:familyName Dübel
82 schema:givenName Stefan
83 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102431427.44
84 rdf:type schema:Person
85 sg:person.01202331433.19 schema:affiliation https://www.grid.ac/institutes/grid.420044.6
86 schema:familyName Moosmayer
87 schema:givenName Dieter
88 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01202331433.19
89 rdf:type schema:Person
90 sg:person.01210437462.56 schema:affiliation https://www.grid.ac/institutes/grid.7892.4
91 schema:familyName Breitling
92 schema:givenName Frank
93 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01210437462.56
94 rdf:type schema:Person
95 sg:person.0622544220.05 schema:affiliation https://www.grid.ac/institutes/grid.420214.1
96 schema:familyName Strebe
97 schema:givenName Nina
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0622544220.05
99 rdf:type schema:Person
100 sg:person.0646353163.21 schema:affiliation https://www.grid.ac/institutes/grid.476513.2
101 schema:familyName Brocks
102 schema:givenName Bodo
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646353163.21
104 rdf:type schema:Person
105 sg:pub.10.1007/bf02789479 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032005049
106 https://doi.org/10.1007/bf02789479
107 rdf:type schema:CreativeWork
108 sg:pub.10.1007/bf03401851 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074947219
109 https://doi.org/10.1007/bf03401851
110 rdf:type schema:CreativeWork
111 https://app.dimensions.ai/details/publication/pub.1082410085 schema:CreativeWork
112 https://doi.org/10.1002/(sici)1099-1352(199903/04)12:2<103::aid-jmr447>3.0.co;2-b schema:sameAs https://app.dimensions.ai/details/publication/pub.1009704394
113 rdf:type schema:CreativeWork
114 https://doi.org/10.1016/0022-1759(94)90334-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033584582
115 rdf:type schema:CreativeWork
116 https://doi.org/10.1016/j.jim.2008.10.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045893716
117 rdf:type schema:CreativeWork
118 https://doi.org/10.1016/s0014-5793(97)00983-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009855139
119 rdf:type schema:CreativeWork
120 https://doi.org/10.1089/hyb.1997.16.227 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059275707
121 rdf:type schema:CreativeWork
122 https://doi.org/10.1128/mcb.5.12.3610 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047737361
123 rdf:type schema:CreativeWork
124 https://www.grid.ac/institutes/grid.420044.6 schema:alternateName Bayer (Germany)
125 schema:name Bayer Schering Pharma AG, Müllerstr. 178, 13342, Berlin, Germany
126 rdf:type schema:Organization
127 https://www.grid.ac/institutes/grid.420214.1 schema:alternateName Sanofi (Germany)
128 schema:name Institut für Biochemie und Biotechnologie, Technische Universität Braunschweig, Spielmannstr. 7, 38106, Braunschweig, Germany
129 Sanofi-Aventis Deutschland GmbH, Industriepark Hoechst, Bldg. H790, 65926, Frankfurt am Main, Germany
130 rdf:type schema:Organization
131 https://www.grid.ac/institutes/grid.476513.2 schema:alternateName MorphoSys (Germany)
132 schema:name Bodo Brocks, MorphoSys AG, Lena-Christ-Str. 48, 82152, Martinsried, Germany
133 rdf:type schema:Organization
134 https://www.grid.ac/institutes/grid.6738.a schema:alternateName Braunschweig University of Technology
135 schema:name Institut für Biochemie und Biotechnologie, Technische Universität Braunschweig, Spielmannstr. 7, 38106, Braunschweig, Germany
136 rdf:type schema:Organization
137 https://www.grid.ac/institutes/grid.7892.4 schema:alternateName Karlsruhe Institute of Technology
138 schema:name Karlsruhe Institute of Technology, Helmholtzplatz 1, 76344 Eggenstein-Leopoldshafen, Germany
139 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...